Work calendars 2022

Do you want to know what holidays and long weekends you have in 2022?

Check your venue’s calendar on the App in two simple steps:

1.Go to “Rovi Information” in the menu

2. Select the “Documentation” section.

Simple, isn’t it? You’ll have updated calendars for all the venues

Log in to the App and don’t miss it.

New content for this Christmas on ROVITECA

ROVITECA returns this festive season full of new content. Don’t miss the new sections:

Enjoy your holidays

Top titles for 2021

Set your goals for 2022

In one day (200 pages)

On the way to…

From the book to the big screen

Your recommendations

Reminder Use of notification box COVID-19

In order to optimise the management of the queries we receive to the mailbox notificacionescovid19@rovi.es, we remind you that it is necessary to identify the name of the employee and their work centre in the subject line of the email.

Remember that if you have symptoms associated with covid-19 or any suspicion of contact with infected people, you should contact your health centre and follow their instructions. You should also report any such incidents to ROVI’s mailbox, as well as any doubts or queries that arise in connection with covid-19.

The Mayor of Alcalá de Henares visits ROVI Laboratories

The Alcalá de Henares plant was visited by the mayor of the city, Javier Rodríguez Palacio, accompanied by the councillor responsible for Urban Planning, Alberto Blázquez Sánchez, and the manager of the Ente Público Empresarial Alcalá Desarrollo, Pilar Fernández Herrador.

Accompanied by the vice-president and CFO, Javier López-Belmonte; the director of the Industrial Area, Miguel Ángel Ortega; and the director of the plant, Pilar García-Morato, the mayor was shown the production activity of the plant, which has an annual production capacity of 3,000 million tablets per year, 100 million final packaged units and 150 million packaged syringes.

During the visit, ROVI management showed the state-of-the-art facilities, highlighting the 12 packaging lines (seven dedicated to injectables) that make it a packaging centre of excellence for in-house and third-party manufacturing. The mayor was also interested in the increased investment in the Alcalá plant and the development of new projects there.

The plant had previously received a visit from the city council of Alcalá de Henares, specifically from the councillor for equality, Patricia Sánchez, who also praised its social initiatives, as well as its participation in the “Empléate desde la Igualdad” programme for reintegrating women into the labour market.

Christmas dinners

We would like to remind you that from next Monday new prevention measures will come into force at ROVI in response to covid-19. These measures are motivated by the increase in the number of infections in the country and the uncertainty caused by the emergence of the omicron variant in the management of the pandemic.

Unfortunately, despite the high vaccination rates, the risk of infection in the face-to-face activities has been increasing in recent weeks. ROVI’s management already took the difficult decision months ago not to hold this year’s traditional Christmas dinner for employees for the second year in a row.

The actual context makes it inadvisable to hold large events in enclosed spaces where minimum prevention measures such as safety distance or the continuous use of masks cannot be guaranteed.

Similarly, we urge departments planning to hold employee Christmas gatherings in the coming weeks to refrain from holding them. We understand that this time of year is a time for celebration and sharing, but we must remember that the only way to prevent infection is to avoid risky situations.

Join the Race for Enterprise 2021

The Race for Enterprise 2021 is here!

Make your team of 2, 3 or 4 runners and show your teammates who is the fastest. If you don’t have a team, don’t worry: we’ll find you one.

If you are not in Madrid but you want to participate in the race, you can sign up in the virtual mode.

What are you waiting for?

  • Date: 19 December at 09:00 am
  • Place: Plaza San Juan de la Cruz (Madrid)
  • Distances: 6.5 km and 10 km

SIGN UP HERE

You have until 10 December

ROVI is once again running for inclusion

Ready…

Steady…

GO!

On Sunday 7 November we once again put on our running shoes for a good cause: the inclusion of people with motor disabilities. Our ROVI colleagues ran together in the Madrid También Solidario race, organised by the También Foundation, which this year celebrated its tenth edition.

This event brought back good feelings and, above all, the pleasure of being reunited after the pandemic. Our colleagues were able to run 1, 5 or 10 km and wanted to share their experience with us.
Don’t miss the video!

ROVI celebrated its Capital Markets Day

ROVI held its Capital Markets Day where it explained to investors and analysts its strategic vision on the evolution of the business, its R&D plans and the main financial figures. It highlights the operating income forecast for this year, which stands at between 588 and 609 million euros, which would bring forward the achievement of the 2023 target by two years.

Another of the main developments announced at this meeting was the resumption of the regulatory process for Risperidone ISM in Europe, following the successful repetition of the clinical bioavailability study and the submission of the information to the European Medicines Agency.

In front of approximately 60 investors or representatives of investment groups, Juan López-Belmonte, President and CEO of ROVI, reviewed what will be its growth drivers for 2022:

  • Low molecular weight heparins, bemiparin and the biosimilar enoxaparin.
  • Distribution licensing agreements, such as Neparvis® and Volutsa®.
  • The existing portfolio of speciality pharmaceuticals
  • The agreement with Moderna for the manufacture of the COVID-19 vaccine.
  • New contracts in the area of third-party manufacturing.

This will be accompanied by a high level of investment in the international arena, with the aim of reaching a presence in 120 countries in the coming years and a sales team specialising in the psychiatric area in Europe, as well as the consolidation of the new plant for the active ingredient Low Molecular Weight Heparins in Granada and the new Moderna manufacturing lines.